TY - JOUR A1 - Zhao, Shaying A1 - Shatsman, Sofiya A1 - Ayodeji, Bola A1 - Geer, Keita A1 - Tsegaye, Getahun A1 - Krol, Margaret A1 - Gebregeorgis, Elizabeth A1 - Shvartsbeyn, Alla A1 - Russell, Daniel A1 - Overton, Larry A1 - Jiang, Lingxia A1 - Dimitrov, George A1 - Tran, Kevin A1 - Shetty, Jyoti A1 - Malek, Joel A. A1 - Feldblyum, Tamara A1 - Nierman, William C. A1 - Fraser, Claire M. T1 - Mouse BAC Ends Quality Assessment and Sequence Analyses Y1 - 2001/10/01 JF - Genome Research JO - Genome Research SP - 1736 EP - 1745 DO - 10.1101/gr.179201 VL - 11 IS - 10 UR - http://genome.cshlp.org/content/11/10/1736.abstract N2 - A large-scale BAC end-sequencing project at The Institute for Genomic Research (TIGR) has generated one of the most extensive sets of sequence markers for the mouse genome to date. With a sequencing success rate of >80%, an average read length of 485 bp, and ABI3700 capillary sequencers, we have generated 449,234 nonredundant mouse BAC end sequences (mBESs) with 218 Mb total from 257,318 clones from libraries RPCI-23 and RPCI-24, representing 15× clone coverage, 7% sequence coverage, and a marker every 7 kb across the genome. A total of 191,916 BACs have sequences from both ends providing 12× genome coverage. The average Q20 length is 406 bp and 84% of the bases havephred quality scores ≥ 20. RPCI-24 mBESs have more Q20 bases and longer reads on average than RPCI-23 sequences. ABI3700 sequencers and the sample tracking system ensure that > 95% of mBESs are associated with the right clone identifiers. We have found that a significant fraction of mBESs contains L1 repeats and ∼48% of the clones have both ends with ≥ 100 bp contiguous unique Q20 bases. About 3% mBESs match ESTs and > 70% of matches were conserved between the mouse and the human or the rat. Approximately 0.1% mBESs contain STSs. About 0.2% mBESs match human finished sequences and > 70% of these sequences have EST hits. The analyses indicate that our high-quality mouse BAC end sequences will be a valuable resource to the community. ER -